Timchalk C, Dryzga M D, Smith F A, Bartels M J
Toxicology Research Laboratory, Dow Chemical Company, Midland, Michigan 48674.
Toxicology. 1991;68(3):291-306. doi: 10.1016/0300-483x(91)90076-d.
The objective of this study was to compare the disposition and metabolism of [14C]1,2-dichloropropane [( 14C]DCP) following oral and inhalation exposure since these two routes are of interest with regards to occupational and accidental exposure. [14C]DCP was administered orally to groups of four rats of each sex as a single dose of 1 or 100 mg/kg and as a multiple 1 mg/kg nonradiolabeled dose for 7 days followed by a single 1 mg [14C]DCP/kg dose on day 8. In addition, four rats of each sex were exposed to [14C]DCP vapors for a 6-h period in a head-only inhalation chamber at target concentrations of 5, 50 and 100 ppm. [14C]DCP was readily absorbed, metabolized and excreted after oral or inhalation exposure. For all treatment groups the principal routes of elimination were via the urine (37-65%) and expired air (18-40%). The tissues, carcass, feces and cage wash contained less than 11, 9.7 and 3.8% of the dose, respectively. The major urinary metabolites, as a group, from the oral and inhalation exposures were identified as three N-acetylcysteine conjugates of DCP, N-acetyl-S-(2-hydroxypropyl)-L-cysteine, N-acetyl-S-(2-oxopropyl)-L-cysteine and N-acetyl-S-(1-carboxyethyl)-L-cysteine. The majority (61-87%) of the expired volatile organic material was found to be parent DCP in all samples analyzed. Increasing the dose/concentration of [14C]DCP resulted in an increase in the amount of exhaled [14C]-volatile organics. The peak DCP blood concentrations (inhalation exposure) were not proportional to dose, indicating a dose-dependency in the blood clearance of DCP. Nonetheless, upon termination of exposure, DCP was rapidly eliminated from the blood. In all treatment groups, following oral and inhalation exposure the majority of the radioactivity was eliminated by 24 h postdosing and no differences were noted between sexes. Therefore, it can be concluded that in the rat the pharmacokinetics and metabolism of [14C]DCP are similar regardless of route of exposure or sex.
本研究的目的是比较口服和吸入暴露后[14C]1,2 - 二氯丙烷([14C]DCP)的处置和代谢情况,因为这两种暴露途径在职业和意外暴露方面都备受关注。将[14C]DCP以1或100 mg/kg的单剂量口服给予每组四只各性别的大鼠,并以1 mg/kg的非放射性多剂量连续给药7天,随后在第8天给予1 mg [14C]DCP/kg的单剂量。此外,每组四只各性别的大鼠在头部吸入舱中以5、50和100 ppm的目标浓度暴露于[14C]DCP蒸气中6小时。口服或吸入暴露后,[14C]DCP很容易被吸收、代谢和排泄。对于所有治疗组,主要的消除途径是通过尿液(37 - 65%)和呼出气体(18 - 40%)。组织、 carcass、粪便和笼冲洗液中所含剂量分别低于11%、9.7%和3.8%。口服和吸入暴露后,作为一组的主要尿液代谢物被鉴定为DCP的三种N - 乙酰半胱氨酸共轭物,即N - 乙酰 - S -(2 - 羟丙基)- L - 半胱氨酸、N - 乙酰 - S -(2 - 氧代丙基)- L - 半胱氨酸和N - 乙酰 - S -(1 - 羧乙基)- L - 半胱氨酸。在所有分析的样品中,发现呼出的挥发性有机物质的大部分(61 - 87%)是母体DCP。增加[14C]DCP 的剂量/浓度会导致呼出的[14C] - 挥发性有机物量增加。DCP的血药峰浓度(吸入暴露)与剂量不成比例,表明DCP的血液清除存在剂量依赖性。尽管如此,暴露终止后,DCP迅速从血液中消除。在所有治疗组中,口服和吸入暴露后,大部分放射性在给药后24小时内消除,且未观察到性别差异。因此,可以得出结论,在大鼠中,无论暴露途径或性别如何,[14C]DCP的药代动力学和代谢情况相似。 (注:原文中carcass未给出合适中文释义,保留英文)